Sanofi (SNYNF)

Market Cap	106.99B -22.4%
Revenue (ttm)	54.85B +5.5%
Net Income	9.17B +40.5%
EPS	7.48 +43.6%
Shares Out	n/a
PE Ratio	11.66
Forward PE	9.16
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,959
Average Volume	79,464
Open	88.00
Previous Close	92.45
Day's Range	88.00 - 89.54
52-Week Range	88.50 - 122.03
Beta	0.37
RSI	39.65
Earnings Date	Apr 23, 2026

About Sanofi

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines protecting against diphtheria, tetanus, pertussis, polio, Hib, and hepatitis B; influenza, COVID-19 vaccine Nuvaxovid, booster, meningitis, and travel and endemic vaccines, that in...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1994
• Employees: 74,846
• Stock Exchange: OTCMKTS
• Ticker Symbol: SNYNF

Financial Performance

In 2025, Sanofi's revenue was 46.72 billion, an increase of 5.49% compared to the previous year's 44.29 billion. Earnings were 7.81 billion, an increase of 40.52%.

Financial numbers in EUR